Instructions for composition and sensitivity

Abstract

Provided herein are methods treating a disease or disorder in or around the eye with a pharmaceutical composition comprising selenium disulfide (SeS2) and instructing the treated individual to limit or avoid exposure to light following administration in order to reduce the adverse effect of the composition.

1 - 45 . (canceled) 
     
     
         46 . A kit for treating a disease or disorder in or around the eye in an individual in need thereof, the kit comprising:
 a pharmaceutical composition comprising a therapeutically effective amount of selenium disulfide (SeS 2 ); and   instructions for administering a therapeutically effective amount of the pharmaceutical composition to an ocular surface, surrounding ocular tissues, or a combination thereof of the individual before bedtime.   
     
     
         47 . A method for treating a disease or disorder in or around the eye in an individual in need thereof, the method comprising:
 administering a therapeutically effective amount of a pharmaceutical composition to an ocular surface, surrounding ocular tissues, or a combination thereof of the individual;   wherein the pharmaceutical composition comprises a therapeutically effective amount of selenium disulfide (SeS 2 ); and   wherein the pharmaceutical composition is administered before bedtime.   
     
     
         48 . A method for treating a disease or disorder in or around the eye in an individual in need thereof, the method comprising:
 protecting an ocular surface of the individual with a barrier; and   administering a therapeutically effective amount of a pharmaceutical composition to the ocular surface of the individual, wherein the pharmaceutical composition comprises a therapeutically effective amount of selenium disulfide (SeS 2 ).